| 000 | 01492 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513073512.0 | ||
| 264 | 0 | _c19930915 | |
| 008 | 199309s 0 0 eng d | ||
| 022 | _a0167-6997 | ||
| 024 | 7 |
_a10.1007/BF00873911 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPfister, D G | |
| 245 | 0 | 0 |
_aA phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer. _h[electronic resource] |
| 260 |
_bInvestigational new drugs _cFeb 1993 |
||
| 300 |
_a53-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aDrugs, Investigational _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGuanidines _xadverse effects |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 700 | 1 | _aBajorin, D | |
| 700 | 1 | _aMotzer, R J | |
| 700 | 1 | _aScher, H | |
| 700 | 1 | _aLouison, C | |
| 700 | 1 | _aHarrison, L | |
| 700 | 1 | _aShah, J | |
| 700 | 1 | _aStrong, E | |
| 700 | 1 | _aBosl, G | |
| 773 | 0 |
_tInvestigational new drugs _gvol. 11 _gno. 1 _gp. 53-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00873911 _zAvailable from publisher's website |
| 999 |
_c8348712 _d8348712 |
||